The world’s first needle-free continuous glucose monitor to prevent and manage diabetes at scale

Developing a non-invasive glucose monitoring device to improve diabetes management and prevent onset for over 2 billion people through EIC blended finance support.

Subsidie
€ 2.500.000
2022

Projectdetails

Introduction

Diabetes is one of the biggest health concerns globally: 6% of the world’s population already lives with diabetes, and another 35% is at a high risk of developing it.

Importance of Monitoring

Proper management of diabetes starts with consistent and accurate monitoring of glucose levels. Yet, most diagnosed diabetics do not monitor their blood sugar as often as prescribed, because it is painful and inconvenient to do so.

Industry Need for Change

This is clear evidence that the €16+ billion glucose monitors industry needs a change – the current methods are not good enough.

Innovative Solution

We have invented, patented, and productized a new technology category for extracting and analysing blood sugar levels in a completely non-invasive way.

Funding Application

We are applying for the EIC blended finance to further miniaturise, optimise, and clinically prove this technology on a wider scale.

Potential Impact

The financing will turn our breakthrough scientific discovery into an end-user device that can potentially impact over 2 billion people by helping them prevent diabetes onset altogether.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.500.000
Totale projectbegroting€ 6.567.443

Tijdlijn

Startdatum1-2-2022
Einddatum31-1-2024
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • GLUCOMODICUM OYpenvoerder

Land(en)

Finland

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

Minimally invasive reliAble Glucose monitoring in Intensive Care

GlucoSet aims to develop a novel continuous glucose monitor for ICU patients to improve glucose control, enhance patient outcomes, and achieve CE-mark approval within 25 months.

€ 2.500.000
EIC Accelerator

Beta-cell recovery to counter diabetes

DiogenX aims to cure Type 1 Diabetes by regenerating pancreatic beta-cells for autonomous insulin release, with plans to out-license the drug following human clinical proof by 2026.

€ 2.500.000
EIC Accelerator

The first universal and price-neutral insulin pen

GO-Pen ApS aims to refine and scale the UNIPEN, an affordable and refillable insulin injection system, to improve dosing accuracy for over 13 million people with diabetes.

€ 2.499.999
EIC Accelerator

Lassie: The first-ever painless breath analyser for people with diabetes, a breakthrough in blood glucose monitoring

Lassie breath analyser BOYDSense aims to provide painless, cost-effective, and discreet diabetes monitoring by analyzing breath VOCs for accurate glucose measurement.

€ 2.500.000

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Unobtrusive Continuous Multi-Metabolite Monitoring for a Physiological Care of Insulin-treated Diabetes

This project aims to revolutionize diabetes management through a fully implantable multi-metabolite monitoring system and automated insulin delivery, enhancing metabolic health and reducing complications.

€ 3.885.462
ERC Proof of...

Affordable and sustainable self-powered GLUCOSE sensing system for a global FAIR diabetes management

FAIRGLUCOSE aims to develop a low-cost, self-powered glucose sensing system that reduces waste and enhances accessibility for glucose monitoring, especially in low-income regions.

€ 150.000
Mkb-innovati...

GlucoMoveIQ

Het project ontwikkelt een subcutane glucosemonitor met hoge nauwkeurigheid en een batterijlevensduur van twee jaar voor betere diabeteszorg.

€ 20.000
EIC Transition

Next generation in-blood glucose monitoring using non-invasive optoacoustic sensing

GLUMON aims to develop a next-gen non-invasive optoacoustic sensor for continuous blood glucose monitoring, enhancing diabetes care and exploring precision nutrition applications.

€ 2.194.210
Mkb-innovati...

Ontwikkeling van een pijnloos en gebruiksvriendelijk glucose-meetsysteem met micronaalden

Het project ontwikkelt een universele applicator voor micronaalden om een innovatieve glucosesensor voor diabetici effectief en consistent op de huid aan te brengen.

€ 345.543